| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $252.2M | +0.3% |
| Cost of Revenue | $54.7M | +15.3% |
| Gross Profit | $197.5M | -3.2% |
| R&D Expense | $36.5M | -14.0% |
| SG&A Expense | $49.3M | -16.3% |
| Operating Income | -$710.8M | -115.5% |
| Interest Expense | $14.8M | -2.4% |
| Pre-tax Income | -$633.7M | -105.6% |
| Income Tax | -$42.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.4M | -19.5% |
| Short-term Investments | $184.8M | +4.3% |
| Accounts Receivable | $53.2M | -10.2% |
| Current Assets | $370.2M | -6.0% |
| Total Assets | $1.09B | -40.3% |
| Current Liabilities | $161.2M | -5.6% |
| Long-term Debt | $244.1M | -5.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.2M | +41.3% |
| Capital Expenditures | $12.3M | +314.6% |
| Investing Cash Flow | -$26.4M | +16.9% |
| Financing Cash Flow | -$56.7M | -121.8% |
| Free Cash Flow | $45.9M | +20.0% |
| -128.0% |
| Net Income | -$413.1M | -104.1% |
| EPS (Basic) | -$3.54 | -97.8% |
| EPS (Diluted) | -$3.54 | -97.8% |
| Total Liabilities |
| $482.2M |
| -23.1% |
| Stockholders' Equity | $607.2M | -49.4% |